Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 443

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 443
---
 deficit                                                                                                                                                                                                 |     |   |  (72,429,528 | ) |     |   |  (68,161,722 | ) |
| Total equity attributable to the shareholders of Aptorum Group Limited                                                                                                                                              |     |   |   21,134,514 |   |     |   |   24,846,236 |   |
| Non-controlling interests                                                                                                                                                                                           |     |   |   (9,357,453 | ) |     |   |   (9,462,883 | ) |
| Total equity                                                                                                                                                                                                        |     |   |   11,777,061 |   |     |   |   15,383,353 |   |
| Total Liabilities and Equity                                                                                                                                                                                        |     | $ |   16,130,223 |   |     | $ |   20,640,091 |   |

See accompanying notes to the consolidated financial statements.

F-3

APTORUM GROUP LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS For Years Ended December 31, 2024, 2023 and 2022 (Stated in U.S. Dollars, except for number of shares)

|                                                                              |     | Year Ended   
 December 31, 
 2024         |            |   |     | Year Ended   
 December 31, 
 2023         |             |   |     | Year Ended   
 December 31, 
 2022         |             |   |
|:-----------------------------------------------------------------------------|:----|:-------------|-----------:|:--|:----|:-------------|------------:|:--|:----|:-------------|------------:|:--|
| Revenue                                                                      |     |              |            |   |     |              |             |   |     |              |             |   |
| Healthcare services income                                                   |     | $            |          — |   |     | $            |     431,378 |   |     | $            |   1,295,889 |   |
| Operating expenses                                                           |     |              |            |   |     |              |             |   |     |              |             |   |
| Cost of healthcare services                                                  |     |              |          — |   |     |              |    (420,812 | ) |     |              |  (1,215,824 | ) |
| Research and development expenses                                            |     |              | (2,195,161 | )